Key Milestones Accomplished

  • 2010-2015: 

    • NIH R01 Grant (NIH/ NIAMS) received to support proof-of-concept studies

  • 2016: 

    • Technology Accelerator Award (Ohio Third Frontier) received for commercialization kick-start

  • 2017-2018:

    • Pilot Translational Grant (NIH Roadmap CTSA/NTSA) received to support IND-enabling activities

  • 2018: 

    • Amplicore Inc. Formed

  • 2019:

    • Jan 7: First Pre-IND meeting with US FDA

    • Department of Defense award ($2M)  received to move AM3101 to clinical trial

    • 1st tranche of $3M closed for the Series Seed raised

Amplicore, Inc.

5412 Courseview Drive, Suite 125

Mason, OH 45204

(513) 204-0084

©2019 by Amplicore